Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Implications of Circadian Variation of Human Endocannabinoid Levels on Obesity Risk

Not Applicable

Not yet recruiting

Conditions: Obesity

Interventions: Behavioral: Late Total Caloric Intake
Behavioral: Early Total Caloric Intake

First Posted Date: 2016-12-22

Last Posted Date: 2024-11-19

Lead Sponsor: University of Chicago

Target Recruit Count: 100

Registration Number: NCT03000803

Circadian Function and Cardio-metabolic Risk in Adrenal Insufficiency

Completed

Conditions: Adrenal Insufficiency

First Posted Date: 2016-12-22

Last Posted Date: 2024-02-28

Lead Sponsor: University of Chicago

Target Recruit Count: 86

Registration Number: NCT03000231

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

Preparing for Kidney Transplant by Attaining a Healthy Weight

Not Applicable

Active, not recruiting

Conditions: Kidney Transplant

Interventions: Other: Exercise
Dietary Supplement: Diet Plan

First Posted Date: 2016-12-08

Last Posted Date: 2024-07-26

Lead Sponsor: University of Chicago

Target Recruit Count: 10

Registration Number: NCT02986243

Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies

Phase 1

Terminated

Conditions: Hematologic Malignancies

Interventions: Drug: Nivolumab

First Posted Date: 2016-12-07

Last Posted Date: 2020-06-25

Lead Sponsor: University of Chicago

Target Recruit Count: 3

Registration Number: NCT02985554

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation

Early Phase 1

Completed

Conditions: Classical Hodgkin Lymphoma
B-cell Non-Hodgkin Lymphoma
Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions: Drug: Pembrolizumab

First Posted Date: 2016-12-05

Last Posted Date: 2024-04-22

Lead Sponsor: University of Chicago

Target Recruit Count: 12

Registration Number: NCT02981914

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma

Phase 2

Active, not recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Elotuzumab
Drug: Carfilzomib
Drug: Lenalidomide
Drug: Dexamethasone

First Posted Date: 2016-11-21

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Target Recruit Count: 47

Registration Number: NCT02969837

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸
NorthShore University Health System, Evanston, Illinois, United States
🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

In-School Evaluation of Bystander: A Game-Based Intervention for Sexual Violence Prevention

Not Applicable

Completed

Conditions: Bystander Behavioral Intentions

Interventions: Behavioral: Bystander, a game-based bystander intervention program
Behavioral: Infection City, a game-based program about meningitis

First Posted Date: 2016-09-29

Last Posted Date: 2023-02-23

Lead Sponsor: University of Chicago

Target Recruit Count: 601

Registration Number: NCT02919098

Locations: 🇺🇸
University of Chicao, Chicago, Illinois, United States

Cannabidiol and Emotional Stimuli

Not Applicable

Completed

Conditions: Drug Addiction

Interventions: Drug: Placebo
Drug: Cannabidiol

First Posted Date: 2016-09-15

Last Posted Date: 2019-08-28

Lead Sponsor: University of Chicago

Target Recruit Count: 38

Registration Number: NCT02902081

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Shift Work and Risk of Cardio-vascular Disease

Completed

Conditions: Shift-Work Sleep Disorder

Interventions: Other: Sleep, Dietary and Cardio-metabolic Measurements

First Posted Date: 2016-09-15

Last Posted Date: 2023-06-02

Lead Sponsor: University of Chicago

Target Recruit Count: 86

Registration Number: NCT02901860

Advanced HIV Prevention (PrEP Chicago)

Not Applicable

Completed

Conditions: HIV

Interventions: Other: Control Group
Behavioral: PrEP Intervention Group

First Posted Date: 2016-09-12

Last Posted Date: 2024-01-18

Lead Sponsor: University of Chicago

Target Recruit Count: 424

Registration Number: NCT02896699

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy